Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls

被引:0
作者
Rehman, Sadia [1 ]
Saba, Nusrat [1 ]
Akhtar, Naveed [2 ]
Munir, Saeeda [1 ]
Ahmed, Waqar [3 ,4 ]
Khanum, Azra [5 ]
机构
[1] Inst Biomed & Genet Engn, G-9-1 Mauve Area, Islamabad 44000, Pakistan
[2] Shifa Tameer E Millat Univ, Shifa Coll Med, Islamabad, Pakistan
[3] Armed Forces Inst Cardiol, Rawalpindi, Pakistan
[4] Natl Inst Heart Dis, Rawalpindi, Pakistan
[5] Pir Mehr Ali Shah Arid Agr Univ, Rawlpindi, Pakistan
关键词
Rheumatic; Heart; Disease; ACE; Polymorphism; Pakistan;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Valve scarring and collagen deposition are crucial in pathogenesis of Rheumatic Heart Disease (RHD), an autoimmune disorder of the heart. Angiotensin I-Converting Enzyme (ACE) plays a major role in fibrous tissue formation. Objectives: The present research work aimed to assess the role of ACE Insertion/Deletion (I/D) polymorphism in progress of RHD. Patients and Methods: DNA was pre pared from blood samples from 156 RHD patients (156) and 204 healthy ethnically-matched controls. Then, it was screened using sequence-specific Primers. Polymerase chain reaction and Agarose gel electrophoresis. The data were analyzed using Vassar stats (http://faculty.vassar.edu/lowry/VassarStats.html). Results: I allele (P = 0.024, OR = 1.42) and II genotype (P = 0.001, OR = 3.07) were significantly higher in Pakistani RHD patients compared to the healthy controls. Also, a significant difference was found between the female, but not male, patients and the controls regarding I allele and II genotype. Conclusions: The study results provided information about involvement of ACE I/D polymorphism in molecular mechanism of RHD. Thus, it can become one of the useful tools in risk assessment and help with designing strategies to combat the disease.
引用
收藏
页码:169 / 172
页数:4
相关论文
共 24 条
  • [1] Atalar E, 2003, J HEART VALVE DIS, V12, P7
  • [2] Braunwald E., 2001, HEART DIS TXB CARDIO
  • [3] The global burden of group A streptococcal diseases
    Carapetis, JR
    Steer, AC
    Mulholland, EK
    Weber, M
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (11) : 685 - 694
  • [4] Association between angiotensin l-converting enzyme gene insertion/deletion polymorphism and mitral valve prolapse syndrome
    Chou, HT
    Chen, YT
    Shi, YR
    Tsai, FJ
    [J]. AMERICAN HEART JOURNAL, 2003, 145 (01) : 169 - 173
  • [5] Cunningham M., 1999, MOL MIMICRY GROUP AS, P135
  • [6] Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases
    Danser, AHJ
    Schunkert, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 410 (2-3) : 303 - 316
  • [7] Davutoglu V, 2005, J HEART VALVE DIS, V14, P277
  • [8] HUBERT C, 1991, J BIOL CHEM, V266, P15377
  • [9] Ismail M, 2004, J BIOCHEM MOL BIOL, V37, P552
  • [10] Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
    Mathew, J
    Sleight, P
    Lonn, E
    Johnstone, D
    Pogue, J
    Yi, QL
    Bosch, J
    Sussex, B
    Probstfield, J
    Yusuf, S
    [J]. CIRCULATION, 2001, 104 (14) : 1615 - 1621